[1]
“Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience”, Ann Med Res , vol. 28, no. 11, pp. 2065–2070, Nov. 2021, Accessed: Jan. 28, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/3977